Joris Maximillian Frenz

3PUBLICATIONS
39CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 08, 2024
Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia.

Eloísa Felipe Fumero, Carolin Walter, Joris Maximillian Frenz

|Sep 27, 2023
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy.

Daria Frank, Pradeep Kumar Patnana, Jan Vorwerk

|Jul 08, 2023
Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo.

Ehsan Bahrami, Jan Philipp Schmid, Vindi Jurinovic

Pageof 1

Frequent Collaborators

3 joint publications

Matthias Mann

3 joint publications

Ashok Kumar Jayavelu

2 joint publications

Martin Dugas

1 joint publications

Ehsan Bahrami